Skip to content Skip to footer

SIGMA-1 EUROPE sponsored symposium

The Croatian Pharmacological Society has a longstanding tradition of hosting successful congresses that bring together leading national and international experts in basic and clinical pharmacology, as well as related disciplines. This year marks the 11th Congress, which will be held in Split, Croatia, from September 25 to 28, 2025. During the Congress, a SIGMA-1 EUROPE–sponsored symposium (Symposium 13) will take place on September 28, presented by SIGMA-1 EUROPE Chair Tangui Maurice together with members of the Action. The program is outlined below:

9:45- 11.15 Symposium S13 – SIGMA-1 EUROPE COST CA23156 Action sponsored symposium: Pharmacology of sigma-1 receptors (Hall B). Organiser: Tangui Maurice

Tangui Maurice: The SIGMA-1 EUROPE CA23156 COST action

Tangui Maurice: Amylovis-201, a new dual-target ligand acting as an anti-amyloidogenic compound and agonist of the sigma-1 chaperone protein, is neuroprotectant in Alzheimer’s disease mouse models

Srećko Gajović: Monitoring time-dependent brain damage and repair after ischemic injury in living animals as tool for evaluation of sigma-1 receptor related preclinical interventions

Urban Košak: A novel therapeutic candidate for Alzheimer’s disease targeting sigma-1, sigma-2, and 5-HT2A receptors and butyrylcholinesterase

Celia Escriche: Unlocking the power of inhibiting soluble epoxide hydrolase and sigma-1 receptor antagonism through dual mechanism analgesic compounds

For more information follow this link

What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST ACTION CA23156

The SIGMA-1 EUROPE Action is dedicated to promoting excellence in research and innovation related to sigma-1 receptor physiopathology and therapeutic applications across multiple fields. This initiative fosters interdisciplinary collaboration to drive breakthrough science and technological advancements in medicinal chemistry and pharmaceutical development.

Action Details

Action Start Date: October 25, 2024
Action End Date: October 24, 2028

© 2025. All rights reserved. – Privacy PolicyPrivacy settings

Created by elaboranext